Nanocarrier Comparisons · Research briefing

Zeta Potential (-20mV to -100mV) Explained: Why Most Liposomal Serums Clump and Degrade on the Shelf

Zeta potential is the single number that best predicts whether a nanovesicle dispersion will still be a dispersion in six months. What it measures, what it does not, and why the −20 to −100 mV window matters.

Answer first

Zeta potential is the electrical potential at the slipping plane around a particle in liquid, and it indicates how strongly neighbouring particles repel. Dispersions beyond about ±25–30 mV usually resist clumping, while near-neutral vesicles aggregate, fuse and leak. Cetosome® nanoparticles are claimed at −20 to −100 mV, with −22 to −55 mV measured across formulations.

What zeta potential actually measures

A particle suspended in water picks up a surface charge from ionised groups, adsorbed ions or charged surfactant headgroups. Counter-ions gather around it in an electrical double layer. When the particle moves, part of that layer moves with it. Zeta potential (ζ) is the electrical potential at the boundary between moving and stationary liquid, called the slipping plane.

It is usually measured by electrophoretic light scattering: an electric field is applied, particle velocity is measured, and the instrument converts that mobility to millivolts. Zeta potential is an inferred value that depends on the model, the dispersant, the pH and especially the ionic strength. Reported values are only comparable when the measurement conditions are stated.[1]

Why the number predicts shelf life

Colloidal particles are always attracted to each other by van der Waals forces. Electrostatic repulsion between like-charged double layers is what keeps them apart. When ζ is small, random collisions overcome the repulsion, and particles flocculate, then aggregate, and vesicles may fuse. A practical rule used across colloid science is that a magnitude of about 25–30 mV or more indicates good electrostatic stability.

The Cetosome® patent uses the same reasoning. It states that ±25 mV or greater is generally sufficient to stabilise a dispersion against flocculation, and claims nanoparticles with a zeta potential of −20 to −100 mV (or +20 to +100 mV).[2]

Reported values

Composition (patent Table 3)

Particle 1 (nm)

Particle 2 (nm)

Zeta potential (mV)

Conductivity (mS/cm)

CLDC0704

82.6 ± 15.8

845.7 ± 114.4

−49.2 ± 1.2

0.016

DPNC1008

95.8 ± 52.5

258.0 ± 68.8

−40.2 ± 2.4

0.027

RDNC1209

602.8 ± 4.8

none detected

−22.3 ± 6.3

0.294

Values are mean ± SE from three batches, each tested in triplicate on a Zetasizer Nano ZS.[2] Across all formulations developed, zeta potentials averaged −22 to −55 mV. A separate measurement on another composition gave −51.6 ± 1.2 mV.

The conductivity lesson

The patent data show an inverse relationship between zeta potential and conductivity and no correlation between zeta potential and particle size.[2] Dissolved salts and ionised actives screen surface charge and compress the double layer. RDNC1209 has the highest conductivity in the table and the lowest |ζ|. It was still stable for 18 months, because the formulation was deliberately tuned for drug stability and skin penetration at higher ionic strength.

For formulators: adding an ionised active or electrolyte to a nanovesicle system can quietly erode its charge-based stability. Measure ζ in the final formulation, not in the placebo base.

Why conventional liposomal serums struggle

Phospholipid liposomes are biocompatible and easy to make, but their known weaknesses are physical and chemical instability: hydrolysis and oxidation of the phospholipids, and aggregation, fusion and leakage during storage.[3] Niosomes, made from non-ionic surfactants, avoid some of the chemical problems but have the same physical ones.[4] Many cosmetic liposomes use neutral or weakly charged lipids, which leaves little electrostatic protection against those processes.

The clinical effect is that a serum can still list "liposomal" on the label while most of its vesicles have fused, grown or released their cargo into the bulk phase. Size growth and a widening polydispersity index (PDI) are early warning signs.[5]

What to ask for

  1. Zeta potential in the final formulation, with pH and conductivity stated.
  2. Particle size distribution (Z-average, PDI, and any second population) at release and after storage.
  3. Real-time stability data (for example 25 °C / 60–65% RH for 12–24 months) covering both particle integrity and active assay, not just accelerated data.
  4. The measurement method and instrument.

A dispersion that keeps its size, its charge and its active content for the whole shelf life is a delivery system. One that does not is an ingredient name on a label.

Frequently asked

What is a good zeta potential for nanoparticles?

A magnitude of about 25–30 mV or more, positive or negative, is generally taken to indicate electrostatic stability against flocculation. The Cetosome® patent cites ±25 mV as the threshold and claims −20 to −100 mV. Measured formulations range from −22 to −55 mV.

Why do liposomal serums lose effectiveness?

Conventional phospholipid liposomes are prone to hydrolysis, oxidation, aggregation, fusion and leakage of their contents during storage. Low surface charge speeds up aggregation, and once vesicles fuse or leak, the encapsulation benefit is gone.

Does zeta potential alone guarantee stability?

No. Steric stabilisation, ionic strength, temperature and chemical degradation all matter. Zeta potential is a strong indicator of colloidal stability, but it should be read alongside real-time stability data on particle size and active content.


References

  1. Bhattacharjee S. DLS and zeta potential — What they are and what they are not?. Journal of Controlled Release 235:337–351. 2016.DOI 10.1016/j.jconrel.2016.06.017
  2. Barathur RR, Bookout JB (assignee: Cymbiotics, Inc.). Topical dermal delivery compositions using self assembling nanoparticles with cetylated components. US Patent US 9,084,818 B2. 2015.Filed 15 Feb 2013; granted 21 Jul 2015. Claim 1 specifies nanoparticle zeta potential of −20 to −100 mV (or +20 to +100 mV). Measured particle diameters of 60–850 nm; claimed physical dimensions 30 nm–5 µm.
  3. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. International Journal of Pharmaceutics 332(1–2):1–16. 2007.DOI 10.1016/j.ijpharm.2006.12.005
  4. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. International Journal of Pharmaceutics 172(1–2):33–70. 1998.DOI 10.1016/S0378-5173(98)00169-0
  5. Danaei M, Dehghankhold M, Ataei S, et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics 10(2):57. 2018.DOI 10.3390/pharmaceutics10020057

Methodology

Content is written from primary sources: granted US patent text, peer-reviewed journals indexed in PubMed or Crossref, and regulator publications. Numerical specifications are quoted exactly as reported in the cited source. Where data are illustrative models rather than measurements, the figure says so.

Conflict of interest & scope

Cetosomes.com is operated in association with parties that manufacture and dispense Cetosome®-based formulations. This site explains vehicle and delivery biophysics; it does not diagnose, treat or prescribe. Clinical decisions belong to a qualified dermatologist or physician. Research articles in the Journal carry no product or brand references.